• Fouzia Amir shifa college of medicine
  • Gulshan Ara
  • Ayesha Basharat
  • Shazia Amir


Background: Oligohydramnios, defined as an amniotic fluid index (AFI) of less than the 5th percentile (at term ≤5 cm, or at per-term ≤8.0 cm), has an incidence of 8.5–15.5%. It is associated with an increased perinatal morbidity and mortality. The objective of this study was to explore whether induction with misoprostol can safely be offered to patients with reduced amniotic fluid index and that vaginal delivery can be achieved without major adverse effects. Method: All women at term who gave consent to be part of the study and required labour induction were recruited. Total 120 women were included in study. They had a per-induction ultrasound to calculate amniotic fluid index (AFI). Based on AFI., the patients were divided into two groups: group 1, had AFI ≤5 cm and was oligohydramnios group. The other was group 2 with normal amniotic fluid, i.e., AFI >5 cm. Both these groups then underwent labour induction with misoprostol (cytotec–Pfizer) 50microgram. The dose was repeated 6 hourly for a maximum of three doses. The outcomes studied were number of tablets used, induction to labour interval, induction to the delivery interval and method of delivery. The foetal outcomes were meconium staining, Apgar score, NICU admission and advance neonatal resuscitation. Results: In maternal parameters, it was observed that there was a significant difference in induction to delivery interval only and in foetal parameters it was observed that in group 1, there was statistical significance in meconium staining, Apgar score and NICU admission. Conclusion: Induction with misoprostol and vaginal delivery can safely be offered to women with oligohydramnios at term.Keywords: misoprostol; induction of labour; oligohydramnios

Author Biography

Fouzia Amir, shifa college of medicine

assistant professorgynecology and obstetrics


Rutherford SE, Jeffrey PP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum foetal heart rate testing. Obstet Gynecol 1987;70(3 Pt 1):353–6.

Sarno AP Jr, Ahn MO, Brar HS, Phelan JP, Platt LD. Intrapartum Doppler velocimetry, amniotic fluid volume, and foetal heart rate as predictors of subsequent foetal distress. I. An initial report. Am J Obstet Gynecol 1989;161(6 Pt 1):1508–14.

Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 1990;162(5):1168–73.

Barss VA, Benacerraf BR, Frigoletto FD Jr. Second trimester oligohydramnios, a predictor of poor foetal outcome. Obstet Gynecol 1984;64(5):608–13.

Mercwe LJ, Brown LG. Foetal outcome with oligohydramnios in the second trimester. Obstet Gynecol 1986;67(6):840–2.

Moore TR, Longo J, Leopold GR, Gosink BB. The reliability and predictive volume of an amniotic fluid scoring system in severe second trimester oligohydramnios. Obstet Gynecol 1989;73(5 Pt 1):739–15.

WHO. WHO recommendations for Induction of labour. Geneva: World Health Organization; 2011.

Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy. Cochrane Database Syst Rev 2002;(2):CD000641.

Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2001;2:CD003101.

Carlan SJ, Blust D, O'Brien WF. Buccal versus intravaginal misoprostol administration for cervical ripening. Am J Obstet Gynecol 2002;186(2):229–33.

Wing DA. Labour induction with misoprostol. Am J Obstet Gynecol 1999;181(2):339–45.

Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: a systematic review. Br J Obstet Gynaecol 1999;106(8):798–803.

Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labour induction: a systematic review of the literature. Clin Obstet Gynecol 2000;43(3):475–88.

Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2003;(1):CD000941.

Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: A systematic review. Br J Obstet Gynaecol 1999;106(8):798–803.

Danielian P, Porter B, Ferri N, Summers J, Templeton A. Misoprostol for induction of labour at term: A more effective agent than dinoprostone vaginal gel. Br J Obstet Gynaecol 1999;106(8):793–7.

Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labour induction. Am J Obstet Gynecol 1995;172(6):1804–10.

Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010;(10):CD000941.

Choi SR. Borderline amniotic fluid index and perinatal outcomes in the uncomplicated term pregnancy. J Matern Foetal Neonatal Med 2016;29(3):457–60.

Petrozella LN, Dashe JS, McIntire DD, Leveno KJ. Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy. Obstet Gynecol 2011;117(2 Pt 1):338–42.

Sultana S, Akbar Khan MN, Khanum Akhtar KA, Aslam M. Low amniotic fluid index in high-risk pregnancy and poor apgar score at birth. J Coll Physicians Surg Pak 2008;18(10):630–4.

Yazsi A. The relation of intrapartum amniotic fluid index to perinatal outcomes. Kafkas J Med Sci 2011;1(1):1–7.

Gumus II, Koktener A, Turhan NO. Perinatal outcomes of pregnancies with borderline amniotic fluid index. Arch Gynecol Obstet 2007;276(1):17–9.

Martínez Medel J, Campillos Maza JM, Lapresta Moros C, Villacampa Pueyo A, Tobajas Homs J. Cervical preinduction and oligoamnios. Ginecol Obstet Mex 2008;76(9):499–506.